Related Experiment Videos
Glucose substrate in myocardial protection
Insights
Glucose-insulin-potassium (GIK) infusion improved myocardial glycogen levels during cardiac surgery. While clinical outcomes were similar, glucose preserved heart muscle glycogen during cardioplegic arrest, suggesting a protective benefit.
Area of Science:
- Cardiology
- Cardiac Surgery
- Metabolic Research
Background:
- Myocardial protection during cardiac surgery is critical.
- Maintaining myocardial glycogen stores may be important for cardiac function.
- Glucose-insulin-potassium (GIK) infusions are used in some cardiac procedures.
Purpose of the Study:
- To investigate the effect of preoperative glucose infusion on myocardial glycogen levels during coronary artery bypass surgery.
- To compare clinical and hemodynamic outcomes between patients receiving glucose and those receiving saline.
Main Methods:
- 30 patients received preoperative GIK infusion with glucose in cardioplegia.
- 30 control patients received saline infusion with no glucose in cardioplegia.
- Myocardial glycogen levels were assessed before bypass and after cardioplegic arrest.
Main Results:
- No significant difference in clinical or hemodynamic parameters between groups.
- Preoperative myocardial glycogen levels were similar in both groups.
- Patients receiving glucose maintained normal myocardial glycogen levels after cardioplegic arrest, unlike the control group.
Conclusions:
- Preoperative glucose infusion, as part of GIK, helps maintain myocardial glycogen stores during cardiac arrest.
- While not affecting immediate clinical outcomes, preserved glycogen may offer long-term myocardial protection.
- Further research is needed to elucidate the clinical significance of maintained glycogen levels.
Abstract:
Glucose-insulin-potassium (GIK) was infused preoperatively in 30 patients scheduled for coronary artery operation. Before cardiopulmonary bypass (CPB) each patient received an intravenous infusion of 50% glucose. Myocardial protection was achieved with a cardioplegic solution containing glucose. A similar group of 30 patients received an equal volume of NaCl infused preoperatively and before CPB, and their cardioplegic solution contained no glucose. Clinically and by hemodynamic evaluation postoperatively one could not separate the two groups. Glycogen grading of the myocardium prior to bypass demonstrated no difference in glycogen levels in patients receiving glucose and those receiving NaCl. However, at the end of cardioplegic arrest only the group receiving glucose maintained normal grading of myocardial glycogen.